Form 4: MiniMed Officer Receives Equity Post-Medtronic Spin-Off

MiniMed Group, Inc. officer John Gyurci acquired 15,322 restricted stock units following the company's separation from Medtronic plc.

Summary

• John Gyurci, Vice President and Chief Accounting Officer of MiniMed Group, Inc. (MMED), acquired 15,322 shares of common stock in the form of restricted stock units (RSUs).
• The acquisition occurred on March 11, 2026, as a conversion of previously held Medtronic plc awards due to MMED's separation from Medtronic, effective March 9, 2026.
• The conversion was executed under the terms of an Employee Matters Agreement (EMA) dated March 1, 2026, between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc.
• The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (LTIP).
• These RSUs will vest in three equal installments on January 26, 2027, January 26, 2028, and January 26, 2029.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a standard, pre-arranged equity conversion following a corporate spin-off, which is generally neutral but provides a positive signal regarding officer retention and long-term incentive alignment.

Positives

• The grant of restricted stock units to a key officer aligns management's interests with long-term shareholder value.
• The conversion of Medtronic awards into MiniMed RSUs ensures continuity of incentive compensation for the officer post-spin-off.

Future Outlook

The acquired restricted stock units are scheduled to vest in three equal annual installments beginning January 26, 2027, providing a long-term incentive for the reporting person.

Industry Context

StockSavvy.ai notes that the conversion of equity awards is a standard and necessary process during corporate spin-offs to ensure that employees of the newly independent entity retain their long-term incentives, aligning their compensation with the performance of the new company.

Comparison to Industry Standards

• The conversion of restricted stock units and performance share units from a parent company (Medtronic) to a spun-off entity (MiniMed Group, Inc.) is a common practice in corporate separations.
• The methodology for conversion, based on average closing trading prices around the separation date, is a typical approach to ensure fair valuation and continuity of equity compensation for employees, consistent with similar spin-offs in the healthcare technology sector.

Corporate Governance

Related Party Transactions

• The equity award conversion is a result of the Employee Matters Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc., which outlines the terms for employee-related matters following the separation of MiniMed Group from Medtronic.

Stakeholder Impact

• Shareholders: The vesting of these RSUs will lead to an increase in outstanding shares over time, representing a standard form of dilution associated with equity compensation plans.
• Employees (specifically John Gyurci): Ensures continuity of long-term incentive compensation post-spin-off, linking their financial interests directly to MiniMed Group's performance.

Next Steps

• The MMED RSUs will vest in three equal installments on January 26, 2027, January 26, 2028, and January 26, 2029.

Key Dates

Recommendation

The filing details a standard equity award conversion for an officer following a corporate spin-off, which does not inherently alter the investment thesis for MiniMed Group, Inc. It represents a pre-arranged compensation event rather than a discretionary open market transaction, thus warranting a 'hold' recommendation as it provides no new fundamental information to change an existing investment stance.

Keywords

MiniMed Group, MMED, Form 4, insider transaction, restricted stock units, RSU, spin-off, Medtronic, equity award conversion, executive compensation